Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal. 1983

Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott

This study was carried out to compare the efficacy of chlormethiazole and chlordiazepoxide in the treatment of acute alcohol withdrawal syndrome in 40 patients. Repeated biochemical, clinical, and psychophysiological measurements were obtained in a randomized, double-blind design in which one group of patients received chlormethiazole and a second group received chlordiazepoxide over a period of 7 days. Analysis indicated both drugs to be of equivalent potency and were equally well tolerated by patients. The more severe aspects of withdrawal were brought under control within the first 4 days of treatment. However, even at 7 days, there still persisted some symptoms attributable to the withdrawal from alcohol.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011604 Psychoses, Alcoholic A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol. Alcoholic Psychoses
D002707 Chlordiazepoxide An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. Methaminodiazepoxide,7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide,7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide,Chlordiazepoxide Hydrobromide,Chlordiazepoxide Hydrochloride,Chlordiazepoxide Monohydrochloride,Chlordiazepoxide Perchlorate,Chlozepid,Elenium,Librium,7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide,7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide,Hydrobromide, Chlordiazepoxide,Hydrochloride, Chlordiazepoxide,Monohydrochloride, Chlordiazepoxide,Perchlorate, Chlordiazepoxide
D002719 Chlormethiazole A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors. Clomethiazole,Distraneurin
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000430 Alcohol Withdrawal Delirium An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175) Alcohol Withdrawal Hallucinosis,Autonomic Hyperactivity, Alcohol Withdrawal Associated,Delirium Tremens,Alcohol Withdrawal Associated Autonomic Hyperactivity,Alcohol Withdrawal-Induced Delirium Tremens,Delirium Tremens, Alcohol Withdrawal Induced,Alcohol Withdrawal Induced Delirium Tremens,Delirium, Alcohol Withdrawal,Hallucinosis, Alcohol Withdrawal

Related Publications

Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
April 1972, Diseases of the nervous system,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
February 1961, Psychopharmacologia,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
May 1988, British journal of addiction,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
January 1985, Alcohol and alcoholism (Oxford, Oxfordshire),
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
April 1975, The British journal of addiction to alcohol and other drugs,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
August 1966, Ugeskrift for laeger,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
October 1969, The British journal of psychiatry : the journal of mental science,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
November 1965, Wisconsin medical journal,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
January 1986, Acta psychiatrica Scandinavica. Supplementum,
Y D Lapierre, and D R Bulmer, and L K Oyewumi, and M L Mauguin, and V J Knott
February 1980, British medical journal,
Copied contents to your clipboard!